TOPLINE: In a real-world diverse population of patients with early triple-negative breast cancer (TNBC), 34% of patients who received pembrolizumab developed immune-related adverse events — findings...
Philip Morris International recently announced that it is opening a manufacturing facility in Aurora to produce its Swedish Match ZYN nicotine pouches. The company is reported...
A recent British Journal of Cancer evaluated the real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer (mTNBC). Study: Real world study of sacituzumab govitecan...